feed,title,long_url,short_url
BioRxiv,PRAK-03202: A triple antigen VLP vaccine candidate against SARS CoV-2,https://biorxiv.org/cgi/content/short/2020.10.30.360115v1?rss=1,https://j.mp/2HP6Yb6
BioRxiv,A cell-free antibody engineering platform rapidly generates SARS-CoV-2 neutralizing antibodies,https://biorxiv.org/cgi/content/short/2020.10.29.361287v1?rss=1,https://j.mp/37XZhu0
BioRxiv,"COVID Moonshot: Open Science Discovery of SARS-CoV-2 Main Protease Inhibitors by Combining Crowdsourcing, High-Throughput Experiments, Computational Simulations, and Machine Learning",https://biorxiv.org/cgi/content/short/2020.10.29.339317v1?rss=1,https://j.mp/34JXKpf
BioRxiv,"Amino acid transporter B0AT1 influence on ADAM17 interactions with SARS-CoV-2 receptor ACE2 putatively expressed in intestine, kidney, and cardiomyocytes",https://biorxiv.org/cgi/content/short/2020.10.30.361873v1?rss=1,https://j.mp/34GoN4E
